Literature DB >> 17245808

Proteomic biomarker identification for diagnosis of early relapse in ovarian cancer.

Jung Hun Oh1, Animesh Nandi, Prem Gurnani, Lynne Knowles, John Schorge, Kevin P Rosenblatt, Jean X Gao.   

Abstract

Ovarian cancer recurs at the rate of 75% within a few months or several years later after therapy. Early recurrence, though responding better to treatment, is difficult to detect. Surface-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry has showed the potential to accurately identify disease biomarkers to help early diagnosis. A major challenge in the interpretation of SELDI-TOF data is the high dimensionality of the feature space. To tackle this problem, we have developed a multi-step data processing method composed of t-test, binning and backward feature selection. A new algorithm, support vector machine-Markov blanket/recursive feature elimination (SVM-MB/RFE) is presented for the backward feature selection. This method is an integration of minimum weight feature elimination by SVM-RFE and information theory based redundant/irrelevant feature removal by Markov Blanket. Subsequently, SVM was used for classification. We conducted the biomarker selection algorithm on 113 serum samples to identify early relapse from ovarian cancer patients after primary therapy. To validate the performance of the proposed algorithm, experiments were carried out in comparison with several other feature selection and classification algorithms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17245808     DOI: 10.1142/s0219720006002399

Source DB:  PubMed          Journal:  J Bioinform Comput Biol        ISSN: 0219-7200            Impact factor:   1.122


  2 in total

1.  The knowledge-integrated network biomarkers discovery for major adverse cardiac events.

Authors:  Guangxu Jin; Xiaobo Zhou; Honghui Wang; Hong Zhao; Kemi Cui; Xiang-Sun Zhang; Luonan Chen; Stanley L Hazen; King Li; Stephen T C Wong
Journal:  J Proteome Res       Date:  2008-07-30       Impact factor: 4.466

2.  Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selection.

Authors:  Carsten Henneges; Dino Bullinger; Richard Fux; Natascha Friese; Harald Seeger; Hans Neubauer; Stefan Laufer; Christoph H Gleiter; Matthias Schwab; Andreas Zell; Bernd Kammerer
Journal:  BMC Cancer       Date:  2009-04-05       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.